The global microbiology testing market is estimated to be USD XX billion in 2016 and is expected to reach USD XX billion by 2021, growing at a CAGR of XX% during the forecast period.
Global Microbiology Testing Market Forecasts (2017 - 2022)
Microbiology testing is a rapidly growing segment of the in-vitro diagnostics industry and is used to check for contamination or presence of microorganisms such as bacteria, yeast, fungi, and viruses in a sample. It is used in various applications such as healthcare (diagnosis of diseases), food (food safety testing), cosmetics (safety testing of cosmetics), and environmental monitoring.
The Food and Drug Administration has set some scientific standards for microbiological testing in various applications. The companies that manufacture drugs, cosmetics, food, etc., use these regulatory standards to ensure that their products are safe for human consumption. Microbiology testing includes analysis of fungi (mold), bacteria (E. coli, Salmonella, Listeria, etc.), mycotoxins, endotoxins, allergens, pollen, and particulates in air, swab, water, dust, bulk, wipe, food, and consumer products.
Drivers and Restraints
Technological advancements like automated instruments for the identification of pathogens, rising incidence of infectious diseases & outbreak of epidemics, growing healthcare expenditure, and rising private-public funding for research on infectious diseases are the key drivers for the global microbiology testing market. Market restraints include laboratory reimbursement issues and the high cost of microbiology instruments.
Global Microbiology Testing Market Segmentation
The market is segmented by application into pharmaceuticals, diagnostics, food testing, cosmetics, environmental applications, and others. The pharmaceutical applications segment holds the largest share in the market, owing to an increase in the number of FDA and MHRA-approved testing laboratories that specialize in the testing of pharmaceutical products and ingredients. The diagnostic applications segment is expected to grow at the highest CAGR during the forecast period due to the rising incidence of infectious diseases and the growing outbreak of epidemics.
The market is segmented by products into instruments and reagents. Market trends show that the instruments segment holds the largest share due to several factors such as the high cost of instruments, increasing technological advances, and the increasing number of automated instruments in laboratories and industries. However, the reagents segment is expected to grow at the highest CAGR as there is an increase in the availability of pathogen-specific reagent and the number of public-private partnerships for research on specific infectious diseases. The market can also be segmented by the disease area into bloodstream infections, gastrointestinal infections, respiratory diseases, sexually transmitted diseases, urinary tract infections, and others.
The market is segmented by geography into North America, Europe, Asia-Pacific, and Rest of the World. North America accounts for the highest market share due to the presence of a large number of market-focused key players providing a wide product portfolio. However, Asia-Pacific is expected to grow at the highest CAGR due to the expanding R&D in new and innovative microbiology testing procedures, the increasing number of hospitals and testing laboratories, and the rising incidence of infectious diseases across India, China, & Japan.
One of the largest market players in the microbiology testing market is:
- Market analysis for the microbiology testing market, with region-specific assessments and competition analysis.
- Market definition along with the identification of key drivers, restraints, opportunities, and challenges.
- Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
- Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information.
- Identification and analysis of the macro and micro factors that affect the global microbiology testing market.
- Insights of the market in the regions that have the highest potential for growth and to also identify the markets that are still untapped.
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Current Market Scenario
6. Drivers, Restraints, Opportunities and Challenges (DROC) Analysis
6.1 Market Drivers
6.1.1 Technological Advancements in Microbiology Testing
6.1.2 Rising Incidence of Infectious Diseases & Outbreak of Epidemics
6.1.3 Growing Healthcare Expenditure
6.1.4 Rising Private-Public Funding for Research on Infectious Diseases
6.2 Market Restraints
6.2.1 Laboratory Reimbursement Issues
6.2.2 High Cost of Microbiology Instruments
6.3.1 Growing Market Demand for Advanced Molecular Diagnostic Products
6.3.2 Improving Healthcare Infrastructure Across the Emerging Markets
6.4.1 Strict Regulatory Policies for Medical Devices
7. Global Microbiology Testing Market Segmentation
7.1 by Application
7.1.1 Pharmaceutical Applications
7.1.2 Diagnostic Applications
18.104.22.168 by Disease Type
22.214.171.124.1 Blood Stream Infections (BSIS)
126.96.36.199.2 Gastrointestinal Infections
188.8.131.52.3 Respiratory Tract Infections
184.108.40.206.4 Sexually Transmitted Diseases
220.127.116.11.5 Urinary Tract Infections
7.1.3 Food & Beverage Testing Applications
7.1.4 Environmental Applications
7.1.5 Cosmetic Applications
7.2 by Product
18.104.22.168 Laboratory Instruments
22.214.171.124.3 Bacterial Colony Counters
126.96.36.199.4 Automated Gram Stainers
188.8.131.52.5 Microbial Culture
184.108.40.206 Microbiology Analyzers
220.127.116.11.1 Molecular Diagnostic Instruments
18.104.22.168.2 Mass Spectrometers
22.214.171.124 Pathogen Specific Kits
126.96.36.199 Common Laboratory Reagents
7.3 by Geography
7.3.1 North America
188.8.131.52 United States of America
184.108.40.206 United Kingdom
220.127.116.11 Spain and Portugal
18.104.22.168 Rest of Europe
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
7.3.4 Middle East & Africa
188.8.131.52 South Africa
184.108.40.206 Rest of Middle East & Africa
7.3.5 South America
220.127.116.11 Rest of South America
8. Porter’s Five Force Analysis
8.1 Bargaining Power of Suppliers
8.2 Bargaining Power of Consumers
8.3 Threat of New Entrants
8.4 Threat of Substitution
8.5 Competitive Rivalry Within the Industry
9. Competitive Landscape
9.1 Mergers and Acquisition Analysis
9.2 Agreements, Collaborations, and Partnerships
9.3 New Product Launches
10. Company Profiles
10.1 Bio-Rad Laboratories Inc.
10.2 Abbott Laboratories
10.3 Becton Dickinson
10.4 Beckman Coulter (Currently Owned by Danaher)
10.5 Alere Inc.
10.6 Roche Holding
10.7 Bruker Corp
10.8 Hologic Corporation
10.9 Cepheid Inc.
10.11 Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Alere Inc.
- Beckman Coulter (Currently Owned by Danaher)
- Becton Dickinson
- Bio-Rad Laboratories Inc.
- Bruker Corp
- Cepheid Inc.
- Hologic Corporation
- Roche Holding
- Thermo Fisher Scientific Inc.